Month: April 2018

Lawsuits are mounting in the U.S. from patients or their surviving families against Swiss pharmaceutical manufacturer Novartis Pharma Stein AG due to complications suffered after use of their leukemia treatment Tasigna® (nilotinib). Lawsuits allege that use of Tasigna causes “severe, accelerated, and irreversible forms of atherosclerosis.” Atherosclerosis is a cardiovascular disease that causes plaque to … Tasigna® Leukemia Medication Linked to Atherosclerosis

Dangerous side effects due to the use of the prescription drug Invokana® have been identified. Since the last time we wrote about Invokana less than a year ago, the number of Invokana cases in the federal court system has increased from 288 to the current count of almost 1,000. As of December 2016, the federal … Invokana® Cases Heading to Trial in 2018